SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe

← ETF Screener

KURE KraneShares MSCI All China Health Care Index ETF

Issuer
KraneShares
Inception
Jan 31, 2018
AUM
$113.5M
Expense ratio
0.79%
Yield
—
Asset class
Equity
Holdings
53
Last price
$18.16

This exchange-traded fund will allocate at least 80% of its net assets, including any capital acquired through borrowing for investment purposes, to financial instruments that are components of its underlying index or exhibit similar economic characteristics. The reference index is a market capitalization-weighted measure, adjusted for free float, and applies a 10/40 Constraint. Its objective is to gauge the equity market performance of Chinese enterprises within the healthcare sector. This fund does not maintain a diversified portfolio.

-11.2%
2025-11-24low 14.52 · high 19.492026-11-20

Performance

1M3MYTD1Y3Y ann.5Y ann.
KURE——————
Equity average (4748 funds)-5.3%-6.8%+27090.2%+22162.3%+27.3%+2.9%

Insider activity in the holdings

Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$309 net.

HoldingWeightInsiders boughtInsiders sold
LEGN LEGEND BIOTECH CORP-ADR0.82%$346K$309K

Holdings · as of Nov 13, 2026

#HoldingWeight
16160.HK BEONE MEDICINES LTD9.64%
21801.HK INNOVENT BIOLOGICS INC8.14%
32269.HK WUXI BIOLOGICS CAYMAN INC7.56%
4603259.SS WUXI APPTEC CO LTD-A5.54%
5600276.SS JIANGSU HENGRUI PHARMACEUT-A4.48%
6300760.SZ SHENZHEN MINDRAY BIO-MEDIC-A4.30%
79926.HK AKESO INC4.15%
81177.HK SINO BIOPHARMACEUTICAL3.91%
91093.HK CSPC PHARMACEUTICAL GROUP LT3.47%
102359.HK WUXI APPTEC CO LTD-H3.19%
113692.HK HANSOH PHARMACEUTICAL GROUP3.09%
121548.HK GENSCRIPT BIOTECH CORP2.80%
13000538.SZ YUNNAN BAIYAO GROUP CO LTD-A2.42%
14688271.SS SHANGHAI UNITED IMAGING HE-A2.41%
151530.HK 3SBIO INC2.11%
166990.HK SICHUAN KELUN-BIOTECH BIOP-H2.09%
17300015.SZ AIER EYE HOSPITAL GROUP CO-A2.02%
18600436.SS ZHANGZHOU PIENTZEHUANG PHA-A1.95%
19002422.SZ SICHUAN KELUN PHARMACEUTIC-A1.85%
20KURE SICHUAN BIOKIN PHARMACEUTI-A1.72%
21300759.SZ PHARMARON BEIJING CO LTD-A1.63%
221099.HK SINOPHARM GROUP CO-H1.57%
23002653.SZ HAISCO PHARMACEUTICAL GROU-A1.31%
24002821.SZ ASYMCHEM LABORATORIES TIAN-A1.30%
252228.HK XTALPI HOLDINGS LTD1.24%
26600196.SS SHANGHAI FOSUN PHARMACEUTI-A1.23%
27300832.SZ SHENZHEN NEW INDUSTRIES BI-A1.20%
282268.HK WUXI XDC CAYMAN INC1.19%
29000963.SZ HUADONG MEDICINE CO LTD-A1.17%
30601607.SS SHANGHAI PHARMACEUTICALS-A1.14%
31000999.SZ CHINA RESOURCES SANJIU MED-A1.04%
32688617.SS APT MEDICAL INC-A1.03%
33688578.SS SHANGHAI ALLIST PHARMACEUT-A0.97%
349995.HK REMEGEN CO LTD-H0.95%
35688331.SS REMEGEN CO LTD-A0.90%
36600085.SS BEIJING TONG REN TANG CO-A0.84%
37002294.SZ SHENZHEN SALUBRIS PHARM-A0.83%
38LEGN LEGEND BIOTECH CORP-ADR0.82%
39002252.SZ SHANGHAI RAAS BLOOD PRODUC-A0.79%
40300765.SZ CSPC INNOVATION PHARMACEUT-A0.74%
41300896.SZ IMEIK TECHNOLOGY DEVELOPME-A0.67%
42300347.SZ HANGZHOU TIGERMED CONSULTI-A0.47%

Sector breakdown

Healthcare99.3%
Consumer Defensive0.7%

Country breakdown

China80.9%
United States15.1%
Hong Kong4.0%

Distributions

DatePer unit
Dec 22, 2025$0.7147
Dec 17, 2024$0.1836
Dec 18, 2023$0.1128
Dec 28, 2022$0.0104
Dec 29, 2021$4.0535
Dec 29, 2020$0.0001
Dec 27, 2019$0.0573
Dec 26, 2018$0.0760

Members of Congress who disclosed this ETF

No member of Congress has disclosed a trade in KURE in the filings we hold.

Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 17, 2026. This is historical data, not investment advice. Report a data error